Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. (Q48025766)

7 February 2018

title

Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. (English)

1 reference

7 February 2018

0 references

Lactococcus lactis

1 reference

1

1 reference

7 February 2018

Aldert Zomer

3

1 reference

7 February 2018

author name string

Yasawardena S

2

1 reference

7 February 2018

Venema G

4

1 reference

7 February 2018

Kok J

5

1 reference

7 February 2018

Leenhouts K

6

1 reference

7 February 2018

language of work or name

English

0 references

publication date

2 March 2006

1 reference

7 February 2018

published in

Vaccine

1 reference

7 February 2018

volume

24

1 reference

7 February 2018

issue

18

1 reference

7 February 2018

page(s)

3900-3908

1 reference

7 February 2018

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

The immune response to Lactococcus lactis: implications for its use as a vaccine delivery vehicle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Cell wall attachment of a widely distributed peptidoglycan binding domain is hindered by cell wall constituents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Novel surface display system for proteins on non-genetically modified gram-positive bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Studies on glycoproteins in the human malaria parasite Plasmodium falciparum. Identification of a myristilated 45kDa merozoite membrane glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Identification of two integral membrane proteins of Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Antibodies and Plasmodium falciparum merozoites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Molecular cloning and nucleotide sequence of the gene encoding the major peptidoglycan hydrolase of Lactococcus lactis, a muramidase needed for cell separation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Antibodies to a merozoite surface protein promote multiple invasion of red blood cells by malaria parasites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Anchoring of proteins to lactic acid bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Receptor binding domain of Escherichia coli F18 fimbrial adhesin FedF can be both efficiently secreted and surface displayed in a functional form in Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Cell surface display system for Lactococcus lactis: a novel development for oral vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Lipoteichoic Acids: A New Class of Bacterial Antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Innate immune recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Mammalian cell expression of malaria merozoite surface proteins and experimental DNA and RNA immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Antibody and clinical responses in volunteers to immunization with malaria peptide-diptheria toxoid conjugates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Model multiple antigenic and homopolymeric peptides from non-repetitive sequences of malaria merozoite proteins elicit biologically irrelevant antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

Nucleotide sequence of the cell wall proteinase gene of Streptococcus cremoris Wg2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.040

7 January 2021

inferred from DOI database lookup

Transformation of Lactococcus by electroporation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16545511

12 December 2020

inferred from PubMed ID database lookup

Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16545511

12 December 2020

inferred from PubMed ID database lookup

Difference between bacterial and food antigens in mucosal immunogenicity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16545511

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/J.VACCINE.2006.02.040

1 reference

7 February 2018

0 references

1 reference

7 February 2018